ELZA-PACE not only improves corneal biomechanics (just like regular CXL) but by flattening the cone significantly, also enhances patients’ visual quality. The results so far indicate that patients treated with this method have better visual outcomes compared to traditional CXL treatments.
Here’s an overview of what ELZA’s surgeons and researchers are presenting in Barcelona this year. ELZA at ESCRS 2024.
ELZA’s medical director, Prof. Dr. Farhad Hafezi MD, PhD, FARVO, was invited to give two lectures this afternoon at the 18th Annual Meeting of the Moroccan Society of Refractive Surgery and Implantology (SAMIR) in Rabat, Morocco.
Discover the latest advancements in keratoconus treatment with the ELZA Institute’s innovative techniques: transPRK, PACE, and All Femto-CAIRS, as featured in The Ophthalmologist.
Prof. Hafezi flew to South Africa to attend OSSA 2024 and give presentations that showcased the latest innovations in corneal cross-linking and biomechanics assessments.
Sunday, September 10th, 2023, continued the trend of informative presentations at the ESCRS 2023 conference in Vienna. Here’s a straightforward rundown of the day’s events:
Total corneal wavefront analysis, facilitated by the MS39 system, represents a significant advancement in therapeutic excimer laser refractive surgery.
The ELZA Institute hosted a highly anticipated educational event and Apéro Riche for Swiss optometrists on June 5, 2023, setting the stage for an enlightening evening of learning and networking.
Emilio Torres-Netto, MD, PhD spoke to Ocular Surgery News about the data he presented at the Winter ESCRS 2023 meeting in Vilamoura, Portugal. He presented
Prof. Farhad Hafezi, Medical Director of the ELZA Institute, was an invited speaker at the International meeting of the Jordan Ophthalmological Society (JOS) 2023 earlier
